Evidence map›Paper›PMID 23135809›Full record

ArticleGenetic epidemiology2013

Exploring the genetic architecture of circulating 25-hydroxyvitamin D.

Linda T Hiraki, Jacqueline M Major, Constance Chen, Marilyn C Cornelis, David J Hunter, Eric B Rimm, Kelly C Simon, Stephanie J Weinstein, Mark P Purdue, Kai Yu and 2 more

Abstract read
In one paragraph

Article in Genetic epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic Predictors of Circulating 25-Hydroxyvitamin D and Prognosis after Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  10. Article
  11. Article
  12. Is calcifediol better than cholecalciferol for vitamin D supplementation?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Linda T HirakiProgram in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02215, USA. lindahiraki@mail.harvard.edu
Jacqueline M Major
Constance Chen
Marilyn C Cornelis
David J Hunter
Eric B Rimm
Kelly C Simon
Stephanie J Weinstein
Mark P Purdue
Kai Yu
Demetrius Albanes
Peter Kraft

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLETT, WALTER C. · 1991 to 2009
$41.8M
A Center for GEI Association StudiesU01HG004424 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2007 to 2010
$21.4M
Dietary Etiology of Heart DiseaseR01HL035464 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ERIC B RIMM, Qi Sun · 1986 to 2026
$13.6M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Genes and Environment Initiatives in Type 2 DiabetesU01HG004399 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HU, FRANK B · 2007 to 2008
$1.2M
Methods to Identify Genetic Markers That Interact with Multiple Environmental ExpR21CA165920 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI KRAFT, PETER · 2012 to 2013
$346k
U S-FINLAND STUDIES OF NUTRITION AND CANCERN01CN045165 · CN · NATIONAL PUBLIC HEALTH INSTITUTE · PI HEINONEN, O · 1985 to 1996
–
FOLLOW UP OF THE ALPHA TOCOPHEROL, BETA CAROTENE LUNGN01CN045035 · CN · NATIONAL PUBLIC HEALTH INSTITUTE · PI VIRTAMO, JARMO · 1994 to 1997
–
CCR NIH HHS HHSN261200800001CCCR NIH HHS N01 RC037004CCR NIH HHS N01-RC-45035CIHRIntramural NIH HHSNCI NIH HHS CA55075NCI NIH HHS HHSN261200800001ENCI NIH HHS HHSN261201000006CNCI NIH HHS N01 CN045035NCI NIH HHS N01 CN045165NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCI NIH HHS P01 CA055075NCI NIH HHS P01CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P01CA087969NCI NIH HHS R21 CA165920NCI NIH HHS U19 CA148065NHGRI NIH HHS 5U01HG004399-2NHGRI NIH HHS U01 HG004399NHGRI NIH HHS U01HG004399NHGRI NIH HHS U01 HG004424NHGRI NIH HHS U01HG04424NHLBI NIH HHS HL35464NHLBI NIH HHS R01 HL035464
6 · The paper itself

Abstract

The primary circulating form of vitamin D is 25-hydroxy vitamin D (25(OH)D), a modifiable trait linked with a growing number of chronic diseases. In addition to environmental determinants of 25(OH)D, including dietary sources and skin ultraviolet B (UVB) exposure, twin- and family-based studies suggest that genetics contribute substantially to vitamin D variability with heritability estimates ranging from 43% to 80%. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) located in four gene regions associated with 25(OH)D. These SNPs collectively explain only a fraction of the heritability in 25(OH)D estimated by twin- and family-based studies. Using 25(OH)D concentrations and GWAS data on 5,575 subjects drawn from five cohorts, we hypothesized that genome-wide data, in the form of (1) a polygenic score comprised of hundreds or thousands of SNPs that do not individually reach GWAS significance, or (2) a linear mixed model for genome-wide complex trait analysis, would explain variance in measured circulating 25(OH)D beyond that explained by known genome-wide significant 25(OH)D-associated SNPs. GWAS identified SNPs explained 5.2% of the variation in circulating 25(OH)D in these samples and there was little evidence additional markers significantly improved predictive ability. On average, a polygenic score comprised of GWAS-identified SNPs explained a larger proportion of variation in circulating 25(OH)D than scores comprised of thousands of SNPs that were on average, nonsignificant. Employing a linear mixed model for genome-wide complex trait analysis explained little additional variability (range 0-22%). The absence of a significant polygenic effect in this relatively large sample suggests an oligogenetic architecture for 25(OH)D.

Indexed as

Genome-Wide Association StudyModels, GeneticMultifactorial InheritancePolymorphism, Single NucleotideAdultAgedCase-Control StudiesCholestanetriol 26-MonooxygenaseCytochrome P450 Family 2FemaleHumansLinear ModelsMaleMiddle AgedOxidoreductases Acting on CH-CH Group DonorsPhenotype25-hydroxyvitamin D7-dehydrocholesterol reductaseCholestanetriol 26-MonooxygenaseCYP2R1 protein, humanCytochrome P450 Family 2Oxidoreductases Acting on CH-CH Group DonorsSteroid HydroxylasesVitamin DVitamin D3 24-Hydroxylase

Identifiers

PMID23135809
PMCPMC3524394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.